Joseph Caprini/LinkedIn
Nov 15, 2025, 08:19
Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
Joseph Caprini, Senior Clinician Educator at The University of Chicago Pritzker School of Medicine, shared on LinkedIn:
”Just released my UIP 2025 session with Alfonso J. Tafur MD MS MBA RPVI on measuring VTE recurrence risk and tailoring treatment.
Dr. Caprini discusses how to pinpoint patients at greatest risk of VTE recurrence and highlights the value of the Caprini Risk Score in guiding long-term prevention.
He also explains how biomarkers, imaging, clinical history, and practical decision frameworks support more precise assessments and determine when extended prophylaxis is warranted.
Stay updated with Hemostasis Today.
-
Feb 25, 2026, 14:23Obi Light Ogbonnia: The Power of Lived Experience in Health Policy and Research
-
Feb 25, 2026, 14:19Can Hormonal Birth Control Cause Blood Clots? – ASH
-
Feb 25, 2026, 14:13AbQader Bedil: 7 Urgent Red Flags in a Peripheral Blood Smear
-
Feb 25, 2026, 14:07Sumedha Dash: Why Whole Blood is Rarely the Answer Anymore?
-
Feb 25, 2026, 14:05Patient Perspectives on HMB in Women with Very Rare Bleeding Disorders – EAHAD
-
Feb 25, 2026, 13:36Zoltan Nagy: Antibody Response Can Shift from Recognizing the Adenoviral Protein to Targeting PF4 in Rare VITT Cases
-
Feb 25, 2026, 13:08Sam K. Saha: Same Clot Against Fast and Slow Systems
-
Feb 25, 2026, 13:04Haykaz Muradyan: The Use of REBOA in Obstetric Haemorrhage
-
Feb 25, 2026, 12:53Jan Hartmann: NexSys Plasma Collection System Receives FDA Clearance